Article Details

BioAge Initiates Phase 2 Trial of BGE-175 to Treat COVID-19 by Reversing Immune Aging, a Key ...

Retrieved on: 2021-03-22 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

BioAge Initiates Phase 2 Trial of BGE-175 to Treat COVID-19 by Reversing Immune Aging, a Key .... View article details on hiswai:

Excerpt

BUSINESS WIRE)--BioAge Labs, Inc., a clinical-stage biotechnology ... populations around the world, largely because the immune system declines ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up